Pain Therapeutics reported $0 in Loan Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US $ 35705M 305M
Biogen BIIB:US $ 6277.4M 1.7M
Cara Therapeutics CARA:US $ 0 0
Eisai 4523:JP Y 84905M 9988M
Eli Lilly And LLY:US $ 14692M 460.9M
Geron GERN:US $ 45.26M 4.92M
Novartis NOVN:VX SF 23784M 589M
Pain Therapeutics PTIE:US $ 0M 0M